Advertisement
U.S. markets closed

Veritas Farms, Inc. (VFRM)

Other OTC - Other OTC Delayed Price. Currency in USD
0.0225-0.0034 (-12.93%)
At close: 03:19PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0259
Open0.0225
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0225 - 0.0225
52 Week Range0.0140 - 0.0730
Volume100
Avg. Volume7,983
Market Cap3.695M
Beta (5Y Monthly)1.16
PE Ratio (TTM)N/A
EPS (TTM)-0.1200
Earnings DateApr 17, 2024 - Apr 21, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for VFRM

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • VERITAS FARMS INC
    Analyst Report: Vertex Pharmaceuticals, Inc.Vertex Pharmaceuticals develops therapies to address cystic fibrosis and other diseases. The company was founded in 1989 in Cambridge, Massachusetts and has 4,800 employees. It has research programs and facilities in the U.S., the UK, and Canada. The shares are a component of the S&P 500.
    Rating
    Fair Value
    Economic Moat
    2 months agoArgus Research
View more